Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,773 | 334 | 99.8% |
| Education | $14.38 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $763.85 | 45 | $0 (2020) |
| PFIZER INC. | $549.12 | 44 | $0 (2020) |
| Genentech USA, Inc. | $409.68 | 21 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $383.62 | 22 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $380.98 | 13 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $355.91 | 22 | $0 (2020) |
| AbbVie Inc. | $355.89 | 21 | $0 (2020) |
| Lilly USA, LLC | $346.30 | 24 | $0 (2020) |
| GlaxoSmithKline, LLC. | $259.14 | 16 | $0 (2020) |
| West-Ward Pharmaceuticals | $194.11 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $339.08 | 15 | Horizon Therapeutics plc ($125.00) |
| 2019 | $1,824 | 104 | Mallinckrodt Enterprises LLC ($237.90) |
| 2018 | $1,932 | 110 | Amgen Inc. ($324.68) |
| 2017 | $1,692 | 108 | PFIZER INC. ($194.81) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/11/2020 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Immunology | ||||||
| 03/05/2020 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: RAYOS | ||||||
| 03/05/2020 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: IMMUNOLOGY | ||||||
| 02/26/2020 | AbbVie Inc. | RINVOQ (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2020 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $12.08 | General |
| Category: Immunology | ||||||
| 02/19/2020 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/12/2020 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Immunology | ||||||
| 01/30/2020 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: IMMUNOLOGY | ||||||
| 01/15/2020 | Amgen Inc. | Enbrel (Biological), Prolia | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Inflammation | ||||||
| 01/14/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2020 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $13.22 | General |
| Category: Immunology | ||||||
| 01/08/2020 | AbbVie Inc. | RINVOQ (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: IMMUNOLOGY | ||||||
| 01/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: RESPIRATORY | ||||||
| 01/06/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2019 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2019 | Regeneron Healthcare Solutions, Inc. | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2019 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Immunology | ||||||
| 12/03/2019 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/26/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2019 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 11/15/2019 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Immunology | ||||||
| 11/13/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Bone Health | ||||||
| 11/08/2019 | Amgen Inc. | Enbrel (Biological), Prolia | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 9 | 466 | 686 | $107,682 | $37,624 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 212 | 398 | $59,362 | $20,080 | 33.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 83 | 103 | $20,475 | $7,274 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 36 | 36 | $9,900 | $4,912 | 49.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 27 | 27 | $6,210 | $1,940 | 31.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $3,380 | $1,665 | 49.3% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2020 | 14 | 18 | $3,600 | $1,180 | 32.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 30 | 30 | $4,020 | $365.76 | 9.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 33 | 39 | $471.00 | $114.90 | 24.4% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation | Office | 2020 | 18 | 22 | $264.00 | $92.05 | 34.9% |
About Dr. Robert Marcus, MD
Dr. Robert Marcus, MD is a Rheumatology healthcare provider based in Massapequa, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619958931.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Marcus, MD has received a total of $5,787 in payments from pharmaceutical and medical device companies, with $339.08 received in 2020. These payments were reported across 337 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,773).
As a Medicare-enrolled provider, Marcus has provided services to 466 Medicare beneficiaries, totaling 686 services with total Medicare billing of $37,624. Data is available for 1 year (2020–2020), covering 9 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Massapequa, NY
- Active Since 11/14/2005
- Last Updated 09/26/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1619958931
Products in Payments
- XELJANZ (Drug) $448.69
- Enbrel (Biological) $410.01
- ACTHAR (Biological) $380.98
- COSENTYX (Biological) $355.91
- Mitigare (Drug) $288.17
- Actemra (Biological) $284.71
- TALTZ (Drug) $269.87
- BENLYSTA (Biological) $259.14
- Humira (Biological) $257.88
- KEVZARA SARILUMAB INJECTION (Biological) $249.20
- RAYOS (Drug) $225.18
- Prolia (Biological) $174.28
- SIMPONI ARIA (Biological) $138.00
- KEVZARA (Biological) $134.42
- Rituxan (Biological) $124.97
- iPro2 (Device) $123.12
- EVENITY (Biological) $116.79
- Durolane (Device) $89.38
- Uloric (Drug) $79.96
- FORTEO (Drug) $76.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.